PS
Prem Sethi
About Prem Sethi
Data last updated:
Prem Sethi is a Whole-Time Director at Entero Healthcare Solutions Limited (since 2018) and Director at Peerless Biotech Private Limited (since 2024). The companies operate in Pharma, Healthcare and Internet. The 2 current companies with reported revenue have a combined latest revenue of ₹6,800 Cr; the largest is Entero Healthcare Solutions Limited at ₹6,610 Cr (FY 2026). Earlier, Prem Sethi was an Additional Director at Avenues Pharma Distributors Private Limited (2019–2020) and Additional Director at Chhabra Healthcare Solutions Private Limited (2019) and 20 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Entero Healthcare Solutions Limited L74999HR2018PLC072204 | Whole-Time Director | 10 Jan 2018 | 2018 | ₹6,610 Cr (FY 2026) | Active |
 Peerless Biotech Private Limited U51397TN2001PTC047094 | Director | 16 Aug 2024 | 2001 | ₹190 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avenues Pharma Distributors Private Limited U24239KA2019PTC122720 | Additional Director | 15 Apr 2019 | 2019 | ₹279 Cr (FY 2025) | Active |
| Chhabra Healthcare Solutions Private Limited U36900DL2018PTC338597 | Additional Director | 19 Jan 2019 | 2018 | ₹64.98 Cr (FY 2025) | Active |
| Viroopa Softech Private Limited U46497DL2015PTC279429 | Director | 25 May 2015 | 2015 | Active | |
| Svmed Solutions Private Limited U51397AP2019PTC111697 | Additional Director | 12 Jun 2019 | 2019 | ₹80.80 Cr (FY 2025) | Active |
| Rada Medisolutions Private Limited U51397TN2019PTC128334 | Additional Director | 21 Aug 2019 | 2019 | ₹81.78 Cr (FY 2025) | Active |
 Novacare Healthcare Solutions Private Limited U51900MH2018PTC309987 | Additional Director | 09 Aug 2018 | 2018 | ₹527 Cr (FY 2025) | Active |
| Sesha Balajee Medisolutions Private Limited U51909AP2019PTC112528 | Additional Director | 12 Nov 2020 | 2019 | ₹95.01 Cr (FY 2025) | Active |
 Ace Cardiopathy Solutions Private Limited U51909DL2009PTC196486 | Additional Director | 28 Nov 2025 | 2009 | ₹156 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Prem Sethi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Sadhanandham | 08445197 | Entero Healthcare Solutions Limited | Nominee Director |
| Kaushik Balakrishnan Natesan | Entero Healthcare Solutions Limited | Cfo | |
| Prabhat Agrawal | 07466382 | Entero Healthcare Solutions Limited , Peerless Biotech Private Limited | Managing Director |
| Prabhat Agrawal | Entero Healthcare Solutions Limited | Ceo | |
| Sandhya Gadkari Sharma | 02005378 | Entero Healthcare Solutions Limited | Director |
| Sanu Vishal Kapoor | Entero Healthcare Solutions Limited | Company Secretary | |
| Sumona Chakraborty | 09597426 | Entero Healthcare Solutions Limited | Nominee Director |
| Vasudevan Sujesh | 08240092 | Entero Healthcare Solutions Limited | Director |
| Raghunathan Sucharithra | 10472433 | Peerless Biotech Private Limited | Director |
| Sambit Mohanty | 09302845 | Peerless Biotech Private Limited | Director |
| Sankar Varadharajan | 10594449 | Peerless Biotech Private Limited | Director |
| Sasidharan Mohan Kumar | 06931860 | Peerless Biotech Private Limited | Whole-Time Director |
| Vinayak Vaikunth Bhat | 00895491 | Peerless Biotech Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prem Sethi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prem Sethi
Prem Sethi currently holds 2 directorships: Entero Healthcare Solutions Limited (Whole-Time Director, since 10 Jan 2018, revenue ₹6,610 Cr (FY 2026)); Peerless Biotech Private Limited (Director, since 16 Aug 2024, revenue ₹190 Cr (FY 2025)).
Prem Sethi was first appointed on 25 May 2015 as Director at Viroopa Softech Private Limited. The most recent appointment on record is 28 Nov 2025 at Ace Cardiopathy Solutions Private Limited.
The 2 current companies of Prem Sethi that report revenue have a combined latest revenue of ₹6,800 Cr: Entero Healthcare Solutions Limited ₹6,610 Cr (FY 2026); Peerless Biotech Private Limited ₹190 Cr (FY 2025).
Prem Sethi held 22 earlier board appointments: Avenues Pharma Distributors Private Limited (Additional Director, 15 Apr 2019 to 29 Dec 2020); Chhabra Healthcare Solutions Private Limited (Additional Director, 19 Jan 2019 to 23 Dec 2019); Viroopa Softech Private Limited (Director, 25 May 2015 to 20 Mar 2017); Svmed Solutions Private Limited (Additional Director, 12 Jun 2019 to 16 Mar 2020); Rada Medisolutions Private Limited (Additional Director, 21 Aug 2019 to 29 Dec 2020); and 17 more.
The current boards of Prem Sethi's companies include Arun Sadhanandham (Entero Healthcare Solutions Limited), Kaushik Balakrishnan Natesan (Entero Healthcare Solutions Limited), Prabhat Agrawal (Entero Healthcare Solutions Limited), Prabhat Agrawal (Entero Healthcare Solutions Limited), Sandhya Gadkari Sharma (Entero Healthcare Solutions Limited), Sanu Vishal Kapoor (Entero Healthcare Solutions Limited), among others.